NCL urges FDA and consumers to take action as GLP-1 shortage ends, but infodemic continues Media Contact: Lisa McDonald, Vice President of Communications, (202)-207-2829 May 22 Conclusion of Mass Compounded GLP-1s Should Bring Clarity but Confusion Reigns Washington, DC Despite the end of the GLP-1 shortage and May 22 FDA-issued deadline for companies to stop mass compounding of the products, the National Consumers League (NCL) is concerned that the epidemic of GLP-1 misinformation will continue to confuse consumers with fake products that can put their health at risk
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Does Medicaid cover weight loss drugs other than GLP-1 shots
Can semaglutide cause lactic acidosis if I take it with metformin
doi: 10.1126/sciadv.adk2444 243 RibasAWeberJSChmielowskiBComin-AnduixBLuDDouekMet al
Whether youre focused on athletic goals, daily wellness, or feeling your best, these tailored panels provide insights into hormone levels, nutrient status, and other important wellness markers
